These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2678304)

  • 41. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients.
    Amery A; Fagard R; Fiocchi R; Lijnen P; Staessen J; Vermylen J
    J Cardiovasc Pharmacol; 1984; 6(1):182-5. PubMed ID: 6199602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ageing, serotonin and ketanserin.
    Breckenridge A
    Drugs; 1988; 36 Suppl 1():44-54. PubMed ID: 3071462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.
    Brogden RN; Sorkin EM
    Drugs; 1990 Dec; 40(6):903-49. PubMed ID: 2079001
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical profile of a new antihypertensive agents. Ketanserin].
    Symoens J
    Rev Med Liege; 1988 Mar; 43 Suppl 1():38-49. PubMed ID: 3287546
    [No Abstract]   [Full Text] [Related]  

  • 45. Mechanism of hypotensive action of ketanserin in men.
    Lijnen P; Fagard R; Staessen J; Vanhees L; Amery A
    Eur Heart J; 1987 Mar; 8(3):308-12. PubMed ID: 3556169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pharmacologic bases of antihypertensive drugs with mechanisms of multi-factor action].
    Van Zwieten PA
    Therapie; 1990; 45 Suppl 2():177-82. PubMed ID: 1971122
    [No Abstract]   [Full Text] [Related]  

  • 47. Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease.
    Frishman WH; Huberfeld S; Okin S; Wang YH; Kumar A; Shareef B
    J Clin Pharmacol; 1995 Jun; 35(6):541-72. PubMed ID: 7665716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Are there reasons to believe that the antihypertensive effects of serotonin (S2) antagonists are age-related?
    Hedner T; Andersson OK; Winther K; Persson B
    J Cardiovasc Pharmacol; 1988; 12 Suppl 8():S132-46. PubMed ID: 2469895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Role of serotonin and its receptors in the pathogenesis of arterial hypertension].
    Belousov IuB; Krivonkin KIu
    Kardiologiia; 1992; 32(11-12):5-9. PubMed ID: 1297881
    [No Abstract]   [Full Text] [Related]  

  • 50. Could the increased antihypertensive efficacy of ketanserin in the elderly be due to altered pharmacokinetics?
    Gould SE; Silas JH; Hosie J
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():89-92. PubMed ID: 2285655
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-performance liquid chromatographic assay with fluorometric detection of ketanserin, a new antihypertensive agent and serotonin S2 antagonist in human plasma, blood and urine.
    Okonkwo PO; Reimann IW; Woestenborghs R; Klotz U
    J Chromatogr; 1983 Feb; 272(2):411-6. PubMed ID: 6833439
    [No Abstract]   [Full Text] [Related]  

  • 52. The mechanism of the antihypertensive effects of ketanserin: a comparison with metoprolol.
    Casiglia E; Gava R; Semplicini A; Nicolin P; Pessina AC
    Br J Clin Pharmacol; 1986 Dec; 22(6):751-2. PubMed ID: 2882774
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of ketanserin on pain perception in arterial hypertension.
    Rosa C; Ghione S
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():133-5. PubMed ID: 2285644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Ketanserin. A new antihypertensive agent with an antagonistic effect on serotonin].
    Kristensen KS; Jensen HA; Svendsen TL
    Ugeskr Laeger; 1990 Mar; 152(12):837-8. PubMed ID: 2316048
    [No Abstract]   [Full Text] [Related]  

  • 55. Influence of ketanserin (serotonin antagonist) on bladder and urethral function.
    Delaere KP; Debruyne FM; Booij LH
    Urology; 1987 Jun; 29(6):669-73. PubMed ID: 3576903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of serotonin blockers in cardiac anesthesia.
    Van der Starre PJ; Reneman RS
    J Cardiothorac Vasc Anesth; 1994 Aug; 8(4):455-62. PubMed ID: 7948806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanism of antihypertensive action of ketanserin in man.
    Schalekamp MA; Wenting GJ
    Br Med J (Clin Res Ed); 1983 Oct; 287(6401):1300-1. PubMed ID: 6315124
    [No Abstract]   [Full Text] [Related]  

  • 58. Retrospective analyses for hypothesis generation. A commentary on the PACK trial (prevention of atherosclerotic complications with ketanserin).
    Chalmers TC; Murray GD
    Clin Exp Hypertens A; 1989; 11(5-6):1117-36. PubMed ID: 2676253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacology of antihypertensive agents with multiple actions.
    van Zwieten PA
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S77-81. PubMed ID: 2200693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New antihypertensive drugs.
    Thind GS
    J Ky Med Assoc; 1978 Apr; 76(4):163-8. PubMed ID: 641407
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.